AKT1 and cancer: Importantly, only simultaneous miR‐126‐3p replacement and miR‐221‐3p inhibition resulted in blockade of AKT phosphorylation, as evaluated and quantified by WB (Fig. 3D) that may subtend the observed reduction in cancer cell viability (Fig. 2A).